Immunogenicity of homologous versus heterologous prime-boost vaccination regimens against SARS-COV-2 in people living with HIV in Argentina: a pilot study

被引:0
|
作者
Mauas, R. [1 ]
Cecchini, D. [1 ]
Uruena, A. [1 ]
Strada, M. [2 ]
Arietti, S. [2 ]
Cassetti, I. [1 ]
机构
[1] Helios Salud, Infect Dis, Buenos Aires, DF, Argentina
[2] Lab Dr Stamboulian, Immunoserol, Buenos Aires, DF, Argentina
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P250
引用
收藏
页码:215 / 215
页数:1
相关论文
共 50 条
  • [1] IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
    Sriphoosanaphan, Supachaya
    Suksawatamnuay, Sirinporn
    Srisoonthorn, Nunthiya
    Siripon, Nipaporn
    Thaimai, Panarat
    Makhasen, Wanwisar
    Mungnamtrakul, Nawakodchamon
    Thanapirom, Kessarin
    Nonthasoot, Bunthoon
    Hansasuta, Pokrath
    Komolmit, Piyawat
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1252 - S1252
  • [2] Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
    Sriphoosanaphan, Supachaya
    Suksawatamnuay, Sirinporn
    Srisoonthorn, Nunthiya
    Siripon, Nipaporn
    Thaimai, Panarat
    Makhasen, Wanwisar
    Mungnamtrakul, Nawakodchamon
    Thanapirom, Kessarin
    Nonthasoot, Bunthoon
    Hansasuta, Pokrath
    Komolmit, Piyawat
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S772 - S772
  • [3] Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
    Zhang, Ruiqi
    Liu, Danlei
    Leung, Ka-Yi
    Fan, Yujing
    Lu, Lu
    Chan, Pui-Chun
    To, Kelvin Kai-Wang
    Chen, Honglin
    Yuen, Kwok-Yung
    Chan, Kwok-Hung
    Hung, Ivan Fan-Ngai
    [J]. VACCINES, 2022, 10 (01)
  • [4] The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
    Ho, Tzu-Chuan
    Chen, Yi-Ming Arthur
    Chan, Hung-Pin
    Chang, Chin-Chuan
    Chuang, Kuo-Pin
    Lee, Che-Hsin
    Yuan, Cheng-Hui
    Tyan, Yu-Chang
    Yang, Ming-Hui
    [J]. VACCINES, 2021, 9 (10)
  • [5] Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines - A prospective multi-center study
    Phuensan, Pawat
    Sirimongkolkasem, Jarongkorn
    Tantawichien, Terapong
    Phannajit, Jeerath
    Kerr, Stephen J.
    Hansasuta, Pokrath
    Chantharit, Prawat
    Wongsa, Adisorn
    Fuengfoo, Pusit
    Chittinandana, Anutra
    Vareesangthip, Kriengsak
    Chayakulkeeree, Methee
    Jangsirikul, Sureeporn
    Schmidt, Araya
    Wanvimonsuk, Kanyika
    Winichakoon, Poramed
    Kajeekul, Rattagan
    Prayoonwiwat, Wichai
    Rerknimitr, Rungsun
    [J]. HELIYON, 2024, 10 (01)
  • [6] Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
    Sriphoosanaphan, Supachaya
    Suksawatamnuay, Sirinporn
    Srisoonthorn, Nunthiya
    Siripon, Nipaporn
    Thaimai, Panarat
    Ananchuensook, Prooksa
    Thanapirom, Kessarin
    Nonthasoot, Bunthoon
    Hansasuta, Pokrath
    Komolmit, Piyawat
    [J]. VACCINES, 2022, 10 (12)
  • [7] Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
    Hyon-Xhi Tan
    Jennifer A. Juno
    Wen Shi Lee
    Isaac Barber-Axthelm
    Hannah G. Kelly
    Kathleen M. Wragg
    Robyn Esterbauer
    Thakshila Amarasena
    Francesca L. Mordant
    Kanta Subbarao
    Stephen J. Kent
    Adam K. Wheatley
    [J]. Nature Communications, 12
  • [8] Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines
    Zhu, Yufan
    Lu, Yingyin
    Zhou, Cail
    Tong, Ganglin
    Gao, Manman
    Zhan, Yan
    Wang, Yan
    Liang, Ran
    Li, Yawei
    Gao, Tianjiao
    Wang, Li
    Zhang, Muyun
    Cheng, Jin
    Gong, Jun
    Wang, Jimin
    Zhang, Wei
    Qi, Junhua
    Cui, Miao
    Zhu, Longchao
    Xiao, Fenglian
    Zhu, Linyu
    Xu, Yunsheng
    Zheng, Zhihua
    Zhou, Zhiyu
    Cheng, Zhengjiang
    Hong, Peng
    [J]. MED, 2022, 3 (08): : 568 - +
  • [9] Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
    Hyon-Xhi Tan
    Juno, Jennifer A.
    Lee, Wen Shi
    Barber-Axthelm, Isaac
    Kelly, Hannah G.
    Wragg, Kathleen M.
    Esterbauer, Robyn
    Amarasena, Thakshila
    Mordant, Francesca L.
    Subbarao, Kanta
    Kent, Stephen J.
    Wheatley, Adam K.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [10] Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
    Markewitz, Robert Daniel Heinrich
    Juhl, David
    Pauli, Daniela
    Goerg, Siegfried
    Junker, Ralf
    Rupp, Jan
    Engel, Sarah
    Steinhagen, Katja
    Herbst, Victor
    Zapf, Dorinja
    Krueger, Christina
    Brockmann, Christian
    Leypoldt, Frank
    Dargvainiene, Justina
    Schomburg, Benjamin
    Sharifzadeh, Shahpour Reza
    Nejad, Lukas Salek
    Wandinger, Klaus-Peter
    Ziemann, Malte
    [J]. VACCINES, 2022, 10 (05)